-
RCKT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Rocket Pharmaceuticals (RCKT)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 51.17 mm | 51.17 mm | 51.17 mm | 51.17 mm | 51.17 mm | 51.17 mm |
Cash burn (monthly) | 37.94 mm | (no burn) | 21.46 mm | 22.52 mm | 18.60 mm | 17.39 mm |
Cash used (since last report) | 62.70 mm | n/a | 35.47 mm | 37.21 mm | 30.73 mm | 28.73 mm |
Cash remaining | -11.52 mm | n/a | 15.71 mm | 13.96 mm | 20.44 mm | 22.44 mm |
Runway (months of cash) | -0.3 | n/a | 0.7 | 0.6 | 1.1 | 1.3 |
13F holders | Current |
---|---|
Total holders | 226 |
Opened positions | 58 |
Closed positions | 24 |
Increased positions | 96 |
Reduced positions | 45 |
13F shares | Current |
---|---|
Total value | 1.33 tn |
Total shares | 112.17 mm |
Total puts | 158.50 k |
Total calls | 154.30 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
RTW Investments | 17.69 mm | $222.34 bn |
Wellington Management | 14.00 mm | $175.92 bn |
BlackRock | 7.10 mm | $89.21 bn |
Vanguard | 6.58 mm | $82.68 bn |
Maverick Capital | 5.20 mm | $65.35 bn |
Westfield Capital Management | 4.71 mm | $59.26 bn |
Citadel Advisors | 4.12 mm | $51.82 bn |
JHG Janus Henderson | 4.00 mm | $50.34 bn |
STT State Street | 3.46 mm | $43.47 bn |
T. Rowe Price | 3.15 mm | $39.58 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Apr 25 | John Militello | Common Stock | Sell | Dispose S | No | No | 7.158 | 718 | 5.14 k | 65,039 |
10 Apr 25 | Shah Gaurav | Common Stock | Buy | Acquire P | No | No | 5.08 | 20,000 | 101.60 k | 792,680 |
9 Apr 25 | Patel Kinnari | Common Stock | Buy | Acquire P | Yes | No | 4.7 | 21,099 | 99.17 k | 26,774 |
4 Apr 25 | Aaron Ondrey | Common Stock | Sell | Dispose S | No | No | 5.294 | 7,489 | 39.65 k | 129,650 |